Pancreatic cancer risk (GLP-1 myth check)
What the FDA labels record as adverse events, each one tied back to the evidence it came from.
Definition
An early worry from rodent studies showing acinar-cell hyperplasia. Large human cohorts and the SELECT trial (Lincoff 2023, PMID 37952131) have NOT shown a pancreatic-cancer signal across years of follow-up, and the 2024 FDA Drug Safety Communication confirmed no causal association is established. ⚠ The boxed warning covers thyroid C-cell tumors and acute pancreatitis — not this. It is worth knowing which warnings are real when someone is frightening you toward or away from a purchase.
SELECT trial deep-dive (long-term safety) →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.
Other terms under Side effects
Where the evidence lives
- SELECT trial deep-dive (long-term safety)
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers